Harman Finochem Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SACUBITRIL/VALSARTAN, with a corresponding US DMF Number 33452.
Remarkably, this DMF maintains an Active status since its submission on February 01, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 27, 2019, and payment made on February 05, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II